These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 19525930)
1. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Takeda A; Baffi JZ; Kleinman ME; Cho WG; Nozaki M; Yamada K; Kaneko H; Albuquerque RJ; Dridi S; Saito K; Raisler BJ; Budd SJ; Geisen P; Munitz A; Ambati BK; Green MG; Ishibashi T; Wright JD; Humbles AA; Gerard CJ; Ogura Y; Pan Y; Smith JR; Grisanti S; Hartnett ME; Rothenberg ME; Ambati J Nature; 2009 Jul; 460(7252):225-30. PubMed ID: 19525930 [TBL] [Abstract][Full Text] [Related]
2. Vision: New light on allergy receptor. Grant M Nature; 2009 Jul; 460(7252):182-3. PubMed ID: 19587753 [No Abstract] [Full Text] [Related]
3. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization. Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355 [TBL] [Abstract][Full Text] [Related]
4. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist. Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125 [TBL] [Abstract][Full Text] [Related]
5. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518 [TBL] [Abstract][Full Text] [Related]
6. CCR3 and choroidal neovascularization. Li Y; Huang D; Xia X; Wang Z; Luo L; Wen R PLoS One; 2011 Feb; 6(2):e17106. PubMed ID: 21358803 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Wang H; Wittchen ES; Jiang Y; Ambati B; Grossniklaus HE; Hartnett ME Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8271-7. PubMed ID: 21917937 [TBL] [Abstract][Full Text] [Related]
9. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability. Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Manousou P; Kolios G; Valatas V; Drygiannakis I; Bourikas L; Pyrovolaki K; Koutroubakis I; Papadaki HA; Kouroumalis E Clin Exp Immunol; 2010 Nov; 162(2):337-47. PubMed ID: 21077277 [TBL] [Abstract][Full Text] [Related]
11. Ontogeny of the eotaxins in human lung. Haley KJ; Sunday ME; Porrata Y; Kelley C; Twomey A; Shahsafaei A; Galper B; Sonna LA; Lilly CM Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L214-24. PubMed ID: 18055844 [TBL] [Abstract][Full Text] [Related]
12. Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration. Wang H; Han X; Kunz E; Hartnett ME Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5525-5534. PubMed ID: 27768790 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation. Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H Mol Vis; 2018; 24():83-93. PubMed ID: 29422766 [TBL] [Abstract][Full Text] [Related]
14. Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of eotaxin-3 (CCL26) and other CCR3 ligands in alveolar type II cells. Taka E; Errahali YJ; Abonyo BO; Bauer DM; Heiman AS Cytokine; 2008 Dec; 44(3):342-51. PubMed ID: 19038554 [TBL] [Abstract][Full Text] [Related]
15. Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage. Li Y; Guo S; Wu X; Wan J; Guan Y; Luo C; Chen Q; Jiang H; Lin H; Qian H; Shi W; Fan W Bioorg Chem; 2024 Jun; 147():107405. PubMed ID: 38696843 [TBL] [Abstract][Full Text] [Related]
16. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation. Abonyo BO; Alexander MS; Heiman AS Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L478-88. PubMed ID: 15863444 [TBL] [Abstract][Full Text] [Related]
17. Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases. Gela A; Kasetty G; Jovic S; Ekoff M; Nilsson G; Mörgelin M; Kjellström S; Pease JE; Schmidtchen A; Egesten A Allergy; 2015 Feb; 70(2):161-70. PubMed ID: 25377782 [TBL] [Abstract][Full Text] [Related]
18. The function of CCR3 on mouse bone marrow-derived mast cells in vitro. Collington SJ; Westwick J; Williams TJ; Weller CL Immunology; 2010 Jan; 129(1):115-24. PubMed ID: 20050333 [TBL] [Abstract][Full Text] [Related]
19. CC chemokine receptor-3 as new target for age-related macular degeneration. Sharma NK; Gupta A; Prabhakar S; Singh R; Bhatt AK; Anand A Gene; 2013 Jul; 523(1):106-11. PubMed ID: 23566847 [TBL] [Abstract][Full Text] [Related]
20. miRNA involvement in angiogenesis in age-related macular degeneration. Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]